undefined undefined
NaN.000
NaN.00%
CAHtalyst™ Pediatric Study Baseline Characteristics Data Highlight Need for Novel Treatments in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH) CAHtalog™ Registry Data of ...
05-04 01:15
AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.32% ...
05-03 02:30
INGREZZA® (valbenazine) First Quarter Net Product Sales of $506 Million Representing 23% Year-Over-Year Growth INGREZZA® SPRINKLE (valbenazine) Capsules Approved by the U.S. FDA Crinecerfont...
05-01 19:00
SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) caps...
05-01 05:12
CNBC Halftime Report Final Trades: Amazon.Com, RTX, AbbVie
05-01 01:01
The Federal Trade Commission (FTC) sent warning letters to 10 drugmakers, including Novo Nordisk (NVO), Teva Pharmaceutical (NYSE:TEVA), and AstraZeneca (NASDAQ:AZN), on Tuesday over questionable pate...
05-01 00:18
Alvotech (NASDAQ:ALVO) has confirmed it will manufacture a high-concentration biosimilar of AbbVie’s (ABBV) blockbuster drug Humira for Cigna’s (CI) Quallent Pharmaceuticals. The Icelandic drugmaker s...
04-30 23:56
Experienced Pharma Executive to Advise on the Firm's Healthcare Investments SAN...
04-30 20:00
A court hearing in an Amgen (NASDAQ:AMGN) patent lawsuit against Sandoz over potential generic entry of its Prolia and Xveva drugs was cancelled. The court hearing in New Jersey was scheduled for tod...
04-30 00:47
加拿大蒙特利尔银行:维持AbbVie(ABBV.US)评级,由优于大市调整至优于大市评级, 目标价由195.00美元调整至180.00美元。
04-29 22:11